Lucid Diagnostics
LUCD
25 hedge funds and large institutions have $2.46M invested in Lucid Diagnostics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
10% more capital invested
Capital invested by funds: $2.24M → $2.46M (+$224K)
4% more funds holding
Funds holding: 24 → 25 (+1)
0.47% less ownership
Funds ownership: 4.38% → 3.91% (-0.47%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$27.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9K |
| 3 |
LPL Financial
San Diego,
California
|
+$5.58K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$1.01K |
| 5 |
Morgan Stanley
New York
|
+$264 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
-$134K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$11.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$8.88K |
| 4 |
Jane Street
New York
|
-$6.56K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.6K |
LUCD Hedge Fund Activity: Q4 2023 in Review
25 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q4 2023, worth a combined $2.46M — up 10% from $2.24M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new LUCD positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $27.5K. The largest seller was Luminus Management, cutting an estimated $134K.
- 25 institutional investors held Lucid Diagnostics (LUCD) as of Q4 2023, up from 24 in Q3 2023.
- Funds reported $2.46M of Lucid Diagnostics stock for Q4 2023, up 10% quarter-over-quarter.
- 3 funds opened new Lucid Diagnostics positions in Q4 2023 and 1 closed out, a net change of +2 holders.
- The largest Lucid Diagnostics buyer in Q4 2023 was Virtu Financial, an estimated $27.5K added.
- The largest Lucid Diagnostics seller in Q4 2023 was Luminus Management, an estimated $134K sold.
Based on aggregated 13F filings for Q4 2023.